Results 181 to 190 of about 113,823 (359)

Investigation of the Suitability of the ROTEM Assay to Measure Coagulation Potential in Blood From Patients on Concizumab Prophylaxis

Haemophilia, EarlyView.
ABSTRACT Background Rotational thromboelastometry (ROTEM) aims to measure the coagulation potential in whole blood. Concizumab, an anti‐tissue factor pathway inhibitor (TFPI) antibody for prophylaxis in haemophilia, enhances tissue factor (TF)‐initiated coagulation by preventing inhibition of activated factor X (FXa), thus increasing thrombin ...
Hermann Eichler, Nora V. Butta, Anne Riddell, Cecilia Augustsson, Marianne Kjalke, Kasper Jensen, Andrea Paramo‐Florencio, Jan Astermark, Pratima Chowdary, Victor Jiménez‐Yuste   +9 more
wiley   +1 more source

Hemophilia gene therapy is effective and safe [PDF]

, 2018
Michael Makris
openalex   +1 more source

Reference Values for the Haemophilia Joint Health Score in Patients With Severe Haemophilia Derived From the Canadian Bleeding Disorder Registry

Haemophilia, EarlyView.
ABSTRACT Background People with haemophilia (PwH) are at increased risk of joint bleeding, often leading to haemophilic arthropathy. The Haemophilia Joint Health Score (HJHS) is widely used to evaluate joint health, but its interpretability is limited by the lack of age‐based reference values.
Khang T. Nguyen, Anthony K. C. Chan, Davide Matino, Emma Iserman, Arun Keepanasseril, Karen Strike   +5 more
wiley   +1 more source

Labeled factor IX kinetics in patients with hemophilia-B [PDF]

, 1981
Kenneth J. Smith, AR Thompson
openalex   +1 more source

Lifetime Cost‐Utility Analysis of Emicizumab Prophylaxis in Severe Haemophilia A Without Inhibitors in China: A Markov Model Analysis

Haemophilia, EarlyView.
ABSTRACT Aim As emicizumab shares no sequence homology with factor VIII (FVIII), in patients with haemophilia A, haemostasis can be restored irrespective of the presence of FVIII inhibitors. Emicizumab, therefore, substantially improved previously available prophylactic options.
Han Bao, Christian Bührer, Ziyi Lin, Li Zhou, Yan Xia, Xiuze Jin, Jianwei Xuan   +6 more
wiley   +1 more source

Transfusion related complications in hemophilia

, 2013
Neelam Marwaha
openalex   +1 more source

Post-operative Bleeding due to Acquired Hemophilia Successfully Treated with Recombinant Factor VIIa: Case Report [PDF]

, 2009
Naria Lee, Seong Hoon Yoon, Won Lim, Mi‐Hyun Kim, Hyo Jeong Kim, Seon Kyeong Kim, Jin Sup Park, Young Mi Seol, Gyung Hyuck Ko, Young Jin Choi, Joo Seop Chung, Goon Jae Cho   +11 more
openalex   +1 more source

Enhancing the Evidence for Care in Underserved Bleeding Disorders Communities

Haemophilia, EarlyView.
ABSTRACT Background Major advances in haemophilia care have not translated equitably across all populations. Individuals with rare bleeding disorders (RBDs), people living in low‐ and lower‐middle‐income countries (LMICs) and women and girls with inherited bleeding disorders (WGWBD) continue to face significant diagnostic, therapeutic and research ...
Johnny Mahlangu
wiley   +1 more source

Prevalence of Hemophilia and Clinicodemographic Characteristics of Hemophilic Patients Aged ≤ 18 Years in Thi-Qar, Iraq

Global Pediatric Health
Objectives . This study aims to determine the prevalence of hemophilia in Thi-Qar, Iraq and study clinical and demographic characteristics of patients with hemophilia. Methods .
Ghada Mansoor Abood FICMS, Raid Kareem Dehiol FICMS, Hayfaa Mohammed Mones FIBMS   +2 more
doaj   +1 more source

Budget impact analysis of use of BPA anti-inhibitor coagulant complex (aicc) and eptacog alfa [activated] in the prophylaxis of bleedings in inhibitor hemophilia patients [PDF]

, 2017
V.G. Serpik, R.I. Yagudinа
openalex   +1 more source